NHS to review making statins available for pharmacists
If only 45% of people with a high risk of cardiovascular disease were identified and treated, 6,000 strokes and heart attacks could be avoided over the next ten years.
Read Moreby Anna Smith | Sep 9, 2019 | News | 0
If only 45% of people with a high risk of cardiovascular disease were identified and treated, 6,000 strokes and heart attacks could be avoided over the next ten years.
Read Moreby Anna Smith | Jan 10, 2019 | News | 0
Statins could bring significant benefits to people with serious mental illnesses such as schizophrenia, bipolar disorder or non-affective psychoses, indicate new findings from UCL-led research.
Read Moreby Selina McKee | May 26, 2017 | News | 0
Patients report more side effects when they know they are taking a statin than when don’t, according to findings of a recent study led by researchers at Imperial College London, funded by Pfizer, and published in The Lancet.
Read Moreby Selina McKee | Sep 9, 2016 | News | 0
A comprehensive review of the efficacy and safety of statins, based on 30 years’ research and published in The Lancet, has concluded that the therapy’s benefits have been underestimated and harms exaggerated.
Read More




PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
